Cargando…
Comparison of risperidone, olanzapine and quetiapine: effects on body weight, serum blood glucose and prolactin
Schizophrenia is a chronic illness with a lifetime prevalence of 1% and with serious physical, social and economic consequences. Over the past decade, atypical antipsychotic medications have become the first-line treatment for schizophrenia (Breier et al, 2005).
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal College of Psychiatrists
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734827/ https://www.ncbi.nlm.nih.gov/pubmed/31507951 |
_version_ | 1783450229609070592 |
---|---|
author | Chaudhry, Haroon Rashid Arshad, Nadia Niaz, Saima Suleman, Tahir Mufti, Khalid A. |
author_facet | Chaudhry, Haroon Rashid Arshad, Nadia Niaz, Saima Suleman, Tahir Mufti, Khalid A. |
author_sort | Chaudhry, Haroon Rashid |
collection | PubMed |
description | Schizophrenia is a chronic illness with a lifetime prevalence of 1% and with serious physical, social and economic consequences. Over the past decade, atypical antipsychotic medications have become the first-line treatment for schizophrenia (Breier et al, 2005). |
format | Online Article Text |
id | pubmed-6734827 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | The Royal College of Psychiatrists |
record_format | MEDLINE/PubMed |
spelling | pubmed-67348272019-09-10 Comparison of risperidone, olanzapine and quetiapine: effects on body weight, serum blood glucose and prolactin Chaudhry, Haroon Rashid Arshad, Nadia Niaz, Saima Suleman, Tahir Mufti, Khalid A. Int Psychiatry Original Article Schizophrenia is a chronic illness with a lifetime prevalence of 1% and with serious physical, social and economic consequences. Over the past decade, atypical antipsychotic medications have become the first-line treatment for schizophrenia (Breier et al, 2005). The Royal College of Psychiatrists 2008-07-01 /pmc/articles/PMC6734827/ /pubmed/31507951 Text en © 2008 The Royal College of Psychiatrists http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article distributed under the terms of the Creative Commons Non-Commercial, No Derivatives (CC BY-NC-ND) license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Chaudhry, Haroon Rashid Arshad, Nadia Niaz, Saima Suleman, Tahir Mufti, Khalid A. Comparison of risperidone, olanzapine and quetiapine: effects on body weight, serum blood glucose and prolactin |
title | Comparison of risperidone, olanzapine and quetiapine: effects on body weight, serum blood glucose and prolactin |
title_full | Comparison of risperidone, olanzapine and quetiapine: effects on body weight, serum blood glucose and prolactin |
title_fullStr | Comparison of risperidone, olanzapine and quetiapine: effects on body weight, serum blood glucose and prolactin |
title_full_unstemmed | Comparison of risperidone, olanzapine and quetiapine: effects on body weight, serum blood glucose and prolactin |
title_short | Comparison of risperidone, olanzapine and quetiapine: effects on body weight, serum blood glucose and prolactin |
title_sort | comparison of risperidone, olanzapine and quetiapine: effects on body weight, serum blood glucose and prolactin |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734827/ https://www.ncbi.nlm.nih.gov/pubmed/31507951 |
work_keys_str_mv | AT chaudhryharoonrashid comparisonofrisperidoneolanzapineandquetiapineeffectsonbodyweightserumbloodglucoseandprolactin AT arshadnadia comparisonofrisperidoneolanzapineandquetiapineeffectsonbodyweightserumbloodglucoseandprolactin AT niazsaima comparisonofrisperidoneolanzapineandquetiapineeffectsonbodyweightserumbloodglucoseandprolactin AT sulemantahir comparisonofrisperidoneolanzapineandquetiapineeffectsonbodyweightserumbloodglucoseandprolactin AT muftikhalida comparisonofrisperidoneolanzapineandquetiapineeffectsonbodyweightserumbloodglucoseandprolactin |